The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| NAOV | -94.68% | -99.7% | -68.75% | -100% |
| S&P | +12.33% | +84.73% | +13.06% | +216% |
NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The firm's products include UroShield and PainShield. It operates through the following geographical segments: United States, Europe, Australia, India, Israel, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Elmsford, NY.
No news articles found for NanoVibronix.
| Q3 2025 | YOY Change | |
|---|---|---|
| Revenue | $0.72M | 92.0% |
| Gross Profit | $0.19M | 42.1% |
| Gross Margin | 26.18% | -9.2% |
| Market Cap | $4.91M | 188.3% |
| Market Cap / Employee | $0.16M | 0.0% |
| Employees | 31 | 93.8% |
| Net Income | $0.60M | 160.1% |
| EBITDA | -$1.99M | -105.2% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q3 2025 | YOY Change | |
|---|---|---|
| Net Cash | $6.98M | 434.9% |
| Accounts Receivable | $0.25M | -56.6% |
| Inventory | 2.2 | -0.3% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $0.02M | -80.5% |
| Short Term Debt | $1.16M | 2257.1% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -11.79% | 39.5% |
| Return On Invested Capital | -240.66% | -21.3% |
| Q3 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$2.00M | -139.0% |
| Operating Free Cash Flow | -$1.97M | -135.6% |
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 3.92 | 0.07 | 0.02 | 0.01 | -98.79% |
| Price to Sales | 0.81 | 0.80 | 0.19 | 1.80 | 245.91% |
| Price to Tangible Book Value | 96.53 | 20.61 | -1.65 | -0.12 | -100.18% |
| Enterprise Value to EBITDA | -1.04 | -2.97 | 0.41 | 0.49 | -187.98% |
| Return on Equity | -160.6% | -28.6% | -23.5% | -15.7% | -83.31% |
| Total Debt | $0.12M | $3.92M | $2.13M | $1.17M | 828.57% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
